Coherus Oncology Inc (CHRS)

Operating Income Growth

28.92%

Quarterly · Period ending:

CHRS logo

CHRS Operating Income Growth

Year-over-year change vs the same period a year earlier

Latest reported28.92%
CHRS Quarterly Operating Income YoY % (-45.79% → 28.92%)
High-resolution chart · PNG

CHRS operating income growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Coherus Oncology Inc Operating Income Growth — Quarterly
Period endingOperating Income Growth
28.921%
20.4336%
-8.602%
-561.2338%
-121.7856%
32.9739%
38.6895%
80.0444%
40.6276%
-0.062%
-33.8143%
60.2158%
21.5164%
16.2867%
-30.2071%
-145.3686%
-82.1429%
51.6462%
-340.7732%
-197.2446%
-136.9989%
-509.5136%
-63.5267%
-34.9627%
137.5514%
346.2076%
174.4323%
190.9938%
161.218%
60.5087%
-30.207%
-0.6306%
20.7069%
41.9584%
36.7465%
-166.9074%
9.7201%
-12.5326%
-40.7091%
218.8157%
-6.5218%
-75.117%
-96.5625%
-1,008.7809%
-228.3253%
-167.0445%
-153.2659%
5.3074%
-93.2141%
-45.7887%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.